Literature DB >> 22272732

Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users.

Nina A Cooperman1, Moonseong Heo, Karina M Berg, Xuan Li, Alain H Litwin, Shadi Nahvi, Julia H Arnsten.   

Abstract

Adherence counseling can improve antiretroviral adherence and related health outcomes in HIV-infected individuals. However, little is known about how much counseling is necessary to achieve clinically significant effects. We investigated antiretroviral adherence and HIV viral load relative to the number of hours of adherence counseling received by 60 HIV-infected drug users participating in a trial of directly observed antiretroviral therapy delivered in methadone clinics. Our adherence counseling intervention combined motivational interviewing and cognitive-behavioral counseling, was designed to include six 30 minute individual counseling sessions with unlimited "booster" sessions, and was offered to all participants in the parent trial. We found that, among those who participated in adherence counseling, dose of counseling had a significant positive relationship with antiretroviral adherence measured after the conclusion of counseling. Specifically, a liner mixed-effects model revealed that each additional hour of counseling was significantly associated with a 20% increase in post-counseling adherence. However, the number of cumulative adherence counseling hours was not significantly associated with HIV viral load, also measured after the conclusion of counseling. Our findings suggest that more intensive adherence counseling interventions may have a greater impact on antiretroviral adherence than less intensive interventions; however, it remains unknown how much counseling is required to impact HIV viral load.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22272732      PMCID: PMC3380183          DOI: 10.1080/09540121.2011.644231

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  24 in total

1.  Directly observed therapy in HIV therapy: A realistic perspective?

Authors:  M Lanzafame; M Trevenzoli; A M Cattelan; P Rovere; A Parrinello
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

2.  Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.

Authors:  James C M Brust; Alain H Litwin; Karina M Berg; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

3.  Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress.

Authors:  Jennifer Adelson Mitty; Valerie E Stone; Michael Sands; Grace Macalino; Timothy Flanigan
Journal:  Clin Infect Dis       Date:  2002-02-27       Impact factor: 9.079

4.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Authors:  D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

5.  Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  D S Metzger; B Koblin; C Turner; H Navaline; F Valenti; S Holte; M Gross; A Sheon; H Miller; P Cooley; G R Seage
Journal:  Am J Epidemiol       Date:  2000-07-15       Impact factor: 4.897

6.  Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.

Authors:  Karina M Berg; Alain Litwin; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

7.  Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.

Authors:  Chinazo O Cunningham; Nancy L Sohler; Nina A Cooperman; Karina M Berg; Alain H Litwin; Julia H Arnsten
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

8.  Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.

Authors:  Karina M Berg; Alain H Litwin; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  Clin Infect Dis       Date:  2011-09-02       Impact factor: 9.079

9.  Factors associated with psychotherapy longevity among HIV-positive patients.

Authors:  Kathryn A Bottonari; Lara M Stepleman
Journal:  AIDS Patient Care STDS       Date:  2009-02       Impact factor: 5.078

10.  Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.

Authors:  Karina M Berg; Jennifer Mouriz; Xuan Li; Elise Duggan; Uri Goldberg; Julia H Arnsten
Journal:  Contemp Clin Trials       Date:  2009-06-06       Impact factor: 2.226

View more
  8 in total

1.  Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

Authors:  N A Mohd Salleh; N Fairbairn; S Nolan; R Barrios; J Shoveller; L Richardson; M-J Milloy
Journal:  HIV Med       Date:  2019-07-29       Impact factor: 3.180

Review 2.  A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs.

Authors:  Meredith Camp Binford; Shoshana Y Kahana; Frederick L Altice
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

3.  Women's perspectives on ImpACT: a coping intervention to address sexual trauma and improve HIV care engagement in Cape Town, South Africa.

Authors:  Brandon A Knettel; Marta I Mulawa; Elizabeth T Knippler; Nonceba Ciya; Corné Robertson; John A Joska; Kathleen J Sikkema
Journal:  AIDS Care       Date:  2019-03-01

Review 4.  Challenges in the Evaluation of Interventions to Improve Engagement Along the HIV Care Continuum in the United States: A Systematic Review.

Authors:  Kathryn A Risher; Sunaina Kapoor; Alice Moji Daramola; Gabriela Paz-Bailey; Jacek Skarbinski; Kate Doyle; Kate Shearer; David Dowdy; Eli Rosenberg; Patrick Sullivan; Maunank Shah
Journal:  AIDS Behav       Date:  2017-07

5.  Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment.

Authors:  Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Yih-Ing Hser; Gregory M Lucas; Amy C Justice; Janet P Tate
Journal:  Drug Alcohol Depend       Date:  2019-09-04       Impact factor: 4.492

Review 6.  The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs.

Authors:  Stefan D Baral; Susanne Strömdahl; Chris Beyrer
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

7.  Implementation and Operational Research: A Time-Motion Analysis of HIV Transmission Prevention Counseling and Antiretroviral Adherence Messages in Western Kenya.

Authors:  Martin C Were; Jason Kessler; Changyu Shen; John Sidle; Stephen Macharia; John Lizcano; Abraham Siika; Kara Wools-Kaloustian; Ann Kurth
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

8.  Impact of a pharmaceutical care program on clinical evolution and antiretroviral treatment adherence: a 5-year study.

Authors:  María Jesús Hernández Arroyo; Salvador Enrique Cabrera Figueroa; Rosa Sepúlveda Correa; María de la Paz Valverde Merino; Alicia Iglesias Gómez; Alfonso Domínguez-Gil Hurlé
Journal:  Patient Prefer Adherence       Date:  2013-08-01       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.